meta_pixel
Tapesearch Logo
Log in
The Story of Money

Moderna’s race to the vaccine

The Story of Money

Manuela Saragosa

Business, Crypto, Markets, Finance, Banking, Investing, History, News

4.4400 Ratings

🗓️ 2 December 2020

⏱️ 21 minutes

🧾️ Download transcript

Summary

The Boston-based biotech eschewed a traditional approach to vaccine development, instead pitching its use of mRNA technology to investors. That pitch paid off this year as the company stands to be one of the first to bring a Covid-19 vaccine to market. Hannah Kuchler, the FT’s US pharma and biotech correspondent, reports on Moderna’s race to find an immunisation for the novel coronavirus.  


The FT is making key coronavirus coverage free to read for everyone. Go to ft.com/coronavirusfree to read the latest.


Read more here: Moderna’s Covid vaccine offers vindication of its unconventional approach


Review clips: Yahoo Finance, CNBC


Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

Am I missing anything? Is this the right decision?

0:02.0

Could it be a alternative?

0:04.0

Am I too late?

0:05.0

Find clarity in your investment decision-making.

0:08.0

Manage your portfolio for sustainable growth

0:11.0

and regulatory alignment

0:12.0

with the ultimate blend of powerful AI and

0:14.6

industry expertise.

0:16.5

Reduce risk, meet your sustainability goals and push the boundaries of possibilities based on

0:21.1

facts, not opinions.

0:23.0

Clarity AI scaling human decisions through tech.

0:26.6

Visit clarity.

0:28.0

AI and take action today.

0:30.3

Before the pandemic, a little known biotech in Boston was trying to invent a new generation of medicines.

0:36.0

So I've been getting to know Moderna ever since I took over this beat in 2019.

0:41.0

I thought they were very interesting,ually, they were interesting financially,

0:45.3

but I never kind of found the way to write about them. They weren't front page news, right?

0:49.1

Until this year. I was talking to the CEO back in January at the J.P. Morgan conference, which is the big health care and biotech and farmer conference of the year in San Francisco.

1:00.0

And it was just as the coronavirus was kind of coming on the horizon.

1:04.3

Think back to January.

1:05.6

Coronavirus was quickly spreading in Wuhan,

1:08.2

but those of us in Europe and in the US

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Manuela Saragosa, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Manuela Saragosa and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.